|
|
|
More rapid HIV disease progression occurs in individuals who have a specific genetic risk factor, according to a new study published online in Nature Immunology. A team of HIV researchers led by Sunil Ahuja studied a risk factor that significantly predicts HIV disease outcome. Individuals who have certain combinations of the two genes CCR5 and CCL3L1 are much more likely to have reduced immune responses and greater decline in numbers of CD4+ T immune cells, two hallmarks of progressive HIV disease.
The significance of the findings is two-fold. Previous work indicated that the influence of the two genes was much more limited that the new data indicate. These findings suggest a means to more effectively predict the course of HIV disease. Author contact: Sunil Ahuja (University of Texas Health Science Center, San Antonio, TX, USA)
E-mail: AHUJAS@uthscsa.edu Abstract available online. (C) Nature Immunology press release.
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|